Brush Up on LMWH Dosing in Special Populations

Questions still come up about low-molecular-weight heparin (LMWH) doses for venous thromboembolism (VTE) in special populations.

We’re using a subcutaneous LMWH, such as enoxaparin, less often now that direct oral anticoagulants (DOACs) are usually preferred.

But when a LMWH is needed, dosing can be tricky in patients with renal impairment, obesity, or who are underweight.